Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages. 2008

Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
Centre for Infectious Diseases, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Summerhall, Edinburgh, EH9 1QH, UK.

Murine gammaherpesvirus 68 (MHV-68) is a natural pathogen of rodents closely related to the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and EBV. Following intranasal infection, the virus replicates in the lung epithelium prior to establishing latent infection in lymphoid tissue. Infection of mice deficient in IFN-gammaR signaling (IFN-gammaR-/-) results in a multiple organ fibrosis, in which the spleen is severely affected. We show here that by Day 12 postinfection, prior to development of fibrosis in the spleens of IFN-gammaR-/- mice, different subsets of splenic macrophages (Mvarphis) are morphologically activated and enter latently infected germinal centers (GCs). Mvarphis coexpressing arginase I (ARG1), a marker of alternative activation of Mvarphis, and murine Mvarphi markers F4/80, ER-TR9, and MOMA-1 are found in GCs of IFN-gammaR-/- mice but not of wild-type mice. Quantitative RT-PCR of spleen RNA confirms induction of ARG1 and in addition, shows up-regulation of found in inflammatory zone 1/resistin-like molecule-alpha, tissue inhibitor of metalloproteinase-1, matrix metalloproteinase-12, fibronectin, and factor XIIIA in IFN-gammaR-/- mice. In contrast, inducible NO synthase, associated with classical Mvarphi activation, is up-regulated following infection of wild-type mice but not IFN-gammaR(-/-) mice. Concomitant with the aaMvarphis, transcription of the Th2 cytokines IL-13, IL-21, and IL-5 is up-regulated. Thus, in the absence of IFN-gammaR signaling, MHV-68 initiates a Th2 immune response, leading to alternative activation of macrophages and induction of fibrosis. This system provides an important model for studying the pathogenesis of fibrosis initiated by a latent herpesvirus infection.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D005854 Germ Cells The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS. Gamete,Gametes,Germ-Line Cells,Germ Line,Cell, Germ,Cell, Germ-Line,Cells, Germ,Cells, Germ-Line,Germ Cell,Germ Line Cells,Germ Lines,Germ-Line Cell
D000096743 Interferon gamma Receptor A heterodimeric receptor composed of two subunits IFNGR1 and IFNGR2. Activated IFNGR1 subunit is believed to form a docking site for SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1). IFNGR2 associates with IFNGR1 to form a receptor for the cytokine interferon gamma (IFNG). CD119 Antigen,CDw119 Antigen,IFN-gamma Receptor 1,IFNGR2 Protein,Interferon gamma Receptor 2,Interferon gamma Receptors,Receptor, Interferon gamma,IFN-gammaR,1, IFN-gamma Receptor,Antigen, CD119,Antigen, CDw119,IFN gamma Receptor 1,IFN gammaR,Protein, IFNGR2,Receptor 1, IFN-gamma,Receptors, Interferon gamma,gamma Receptor, Interferon,gamma Receptors, Interferon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription

Related Publications

Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
April 2020, Arthritis research & therapy,
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
July 2015, Nature reviews. Gastroenterology & hepatology,
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
January 2013, Methods in molecular biology (Clifton, N.J.),
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
January 2009, Methods in molecular biology (Clifton, N.J.),
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
May 2015, Nature communications,
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
June 2016, The Journal of clinical investigation,
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
February 2015, Clinical immunology (Orlando, Fla.),
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
January 2015, Mediators of inflammation,
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
January 2012, Contemporary oncology (Poznan, Poland),
Babunilayam Gangadharan, and Marieke A Hoeve, and Judith E Allen, and Bahram Ebrahimi, and Susan M Rhind, and Bernadette M Dutia, and Anthony A Nash
July 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
Copied contents to your clipboard!